Erin H Christensen

Title: Erin H Christensen: Innovator in Antibody Technology

Introduction

Erin H Christensen is a prominent inventor based in Tiburon, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody technologies. With a total of 3 patents to her name, Erin has established herself as a key figure in her industry.

Latest Patents

Among her latest patents is the invention titled "Multivalent and multiepitopic antibodies having agonistic activity and methods of use." This patent describes tetravalent antigen binding complexes that exhibit agonist activity for a cell surface receptor. The complexes are designed to have binding specificities for multiple epitopes of the same receptor. Additionally, Erin has developed nucleic acids, vectors, host cells, pharmaceutical compositions, and methods of production related to these complexes. Another notable patent is "Coiled coil and/or tether containing protein complexes and uses thereof." This invention provides engineered protein complexes constructed using a coiled coil and/or a tether, along with methods for making, using, and purifying such complexes, including multispecific antibodies.

Career Highlights

Erin H Christensen is currently employed at Genentech, Inc., where she continues to push the boundaries of antibody research and development. Her work has been instrumental in advancing therapeutic options in the biotechnology sector.

Collaborations

Throughout her career, Erin has collaborated with esteemed colleagues, including Bernd Wranik and Dan L Eaton. These partnerships have fostered innovation and contributed to the success of her projects.

Conclusion

Erin H Christensen is a trailblazer in the field of antibody technology, with a strong portfolio of patents and a commitment to advancing biotechnological solutions. Her contributions are shaping the future of therapeutic development.